Author

Jessica Chicola

Observed name: J. Chicola

Institution: Cooper Medical School of Rowan University

Observed institutions: Memorial Sloan Kettering Cancer Center, Cooper Medical School of Rowan University

OpenAlex ID: A5115006549

289 | Multicenter Real‐world Outcomes of Frontline Pola‐r‐chp in Treatment Naïve Dlbcl

2025 · S. K. Thiruvengadam, L. Chen, et al. · Hematological Oncology · 4

Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

2024 · Varun Iyengar, Jessica Chicola, et al. · Blood · 2

Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma

2025 · Varun Iyengar, Jomel Meeko Manzano, et al. · Blood · 1

Real-world outcomes of frontline polatuzumab and impact of frailty in older adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL), a multicenter study

2026 · P. Torka, J. Meeko Manzano, et al. · Journal of Geriatric Oncology

POSTER: ABCL-817 Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study

2025 · Jessica Chicola, Jomel Meeko Manzano, et al. · Clinical Lymphoma Myeloma & Leukemia

ABCL-817: Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study

2025 · Jessica Chicola, Jomel Meeko Manzano, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 6

Citation count: 7

H-index: 2

I10-index: